Purdue Institute for Cancer Research shared on LinkedIn:
“A new imaging system developed by Purdue Institute for Cancer Research investigator David Nolte is being used to assess experimental chemotherapy drugs for osteosarcoma, with the goal of identifying treatments best suited to individual tumors.”
Purdue University scientist David Nolte is developing an AI-powered imaging system that uses laser light and the Doppler effect to detect microscopic movements within living tumor cells and predict their responses to chemotherapy. The technology, known as biodynamic imaging, is currently being tested on patient-derived osteosarcoma models to evaluate experimental chemotherapy drugs. The research aims to help identify the most effective treatments for individual patients, potentially enabling doctors to make personalized chemotherapy decisions within 48 hours of a biopsy.
Read more about this innovative imaging technology.
You can also read: Methotrexate for Osteosarcoma: Uses, Benefits and Side Effects
